Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

OBJECTIVE: Long-standing evidence indicates that Alzheimer's disease patients with behavioral symptoms have a worse prognosis and a more rapid disease progression. The current retrospective analysis evaluated the efficacy and safety of memantine in a subpopulation of patients with Alzheimer�...

Full description

Bibliographic Details
Main Authors:	Wilcock, G, Ballard, C, Cooper, J, Loft, H
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
by: Wilcock, G, et al.
Published: (2006)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
by: Howard, R, et al.
Published: (2012)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
by: Jones, R, et al.
Published: (2009)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
by: Wilcock, G
Published: (2007)

Donepezil for the treatment of agitation in Alzheimer's disease.
by: Howard, R, et al.
Published: (2007)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
by: Howard, R, et al.
Published: (2012)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
by: Schneider, L, et al.
Published: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
by: Schneider, L, et al.
Published: (2011)

Memantine for the treatment of dementia.
by: Wilcock, G
Published: (2003)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
by: Wilcock, G, et al.
Published: (2003)

The clinical use of memantine
by: Burns, A, et al.
Published: (2005)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
by: Farrimond, L, et al.
Published: (2012)

Prevalence and correlates of aggressive behaviours occurring in patients with Alzheimer's disease.
by: Eastley, R, et al.
Published: (1997)

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
by: Ballard, C, et al.
Published: (2009)

Memantine for dementia.
by: Mcshane, R, et al.
Published: (2006)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
by: Wilcock, G, et al.
Published: (1982)

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
by: Wilcock, G, et al.
Published: (2002)

Analysing the effect of CSF inflammatory proteins on stroke severity in people with varying severities of Alzheimer's disease
by: Chan, Shawn Kiat Zhong
Published: (2023)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1983)

DAILY VARIATIONS IN SLEEP-WAKE PATTERNS AND SEVERITY OF PSYCHOSIS
by: Waters, F, et al.
Published: (2010)

Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease
by: Chan, L, et al.
Published: (2011)

Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease.
by: Chan, L, et al.
Published: (2011)

Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.
by: Minger, S, et al.
Published: (2001)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Sleep disorders in early psychosis: Incidence, severity, and association with clinical symptoms
by: Reeve, S, et al.
Published: (2017)

The association between continuity of care and readmission to hospital in patients with severe psychosis
by: Puntis, S, et al.
Published: (2016)

Searching for a common pooling pattern among several samples
by: Álvarez-Esteban, P, et al.
Published: (2013)

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD).
by: Ballard, C, et al.
Published: (2015)

Moderate and severe disabilities : a foundational approach /
by: 337680 Collins, Belva C.
Published: (2007)

Curriculum and assessment for students with moderate and severe disabilities /
by: 314717 Browder, Diane M.
Published: (2001)

Associations of event-related brain potentials and Alzheimer’s disease severity: a longitudinal study
by: Fruehwirt, W, et al.
Published: (2018)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
by: Robinson, DE, et al.
Published: (2021)

Age and Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1983)

Treating Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1995)

Galantamine in Alzheimer's disease.
by: Razay, G, et al.
Published: (2008)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994)

Herpesviruses in brain and Alzheimer's disease.
by: Lin, W, et al.
Published: (2002)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1990)